News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Readnour Robin Shane
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Readnour Robin Shane (Director) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Granted 23,742 options to buy
@ $5.91, valued at
$140.3k
|
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Readnour Robin Shane (Director) has filed a Form 4 on AN2 Therapeutics, Inc.|
Txns:
| Converted 285,156 shares
@ $0
Converted 333,135 shares
@ $0
Converted 61,491 shares
@ $0
Converted 71,839 shares
@ $0
Bought 70,716 shares
@ $15, valued at
$1.1M
Bought 82,618 shares
@ $15, valued at
$1.2M
Converted 285,156 convertible preferred
@ $0
Converted 333,135 convertible preferred
@ $0
Converted 61,491 convertible preferred
@ $0
Converted 71,839 convertible preferred
@ $0 |
|
|
|